Advanced search
Publication Cover
Current Medical Research and Opinion Volume 22, 2006 - Issue 7
Submit an article Journal homepage
91
Views
8
CrossRef citations to date
0
Altmetric
Original Article

Acarbose in addition to existing treatments in patients with type 2 diabetes: health economic analysis in a German setting

Stéphane Roze CORE – Center for Outcomes Research, Binningen, SwitzerlandCorrespondence[email protected]
,
William J. Valentine CORE – Center for Outcomes Research, Binningen, Switzerland
,
Thomas Evers Bayer HealthCare, Leverkusen, Germany
&
Andrew J. Palmer CORE – Center for Outcomes Research, Binningen, Switzerland
Pages 1415-1424 | Accepted 12 May 2006, Published online: 15 Jun 2006

Citations (8)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Victoria K. Brennan, Ann D. Colosia, Catherine Copley-Merriman, Josephine Mauskopf, Bastian Hass & Roberto Palencia. (2014) Incremental costs associated with myocardial infarction and stroke in patients with type 2 diabetes mellitus: an overview for economic modeling. Journal of Medical Economics 17:7, pages 469-480.
Read now
Y. Yi, Z. Philips, G. Bergman & K. Burslem. (2010) Economic models in type 2 diabetes. Current Medical Research and Opinion 26:9, pages 2105-2118.
Read now

Articles from other publishers (6)

Xinyang Hua, Thomas Wai-Chun Lung, Andrew Palmer, Lei Si, William H. Herman & Philip Clarke. (2016) How Consistent is the Relationship between Improved Glucose Control and Modelled Health Outcomes for People with Type 2 Diabetes Mellitus? a Systematic Review. PharmacoEconomics 35:3, pages 319-329.
Crossref
Xiaolong Chen, Yuele Lu, Yongxian Fan & Yinchu Shen. 2017. Validamycin and its Derivatives. Validamycin and its Derivatives 237 278 .
Mi Young LeeDong Seop ChoiMoon Kyu LeeHyoung Woo LeeTae Sun ParkDoo Man KimChoon Hee ChungDuk Kyu KimIn Joo KimHak Chul JangYong Soo ParkHyuk Sang KwonSeung Hun LeeHee Kang Shin. (2014) Comparison of Acarbose and Voglibose in Diabetes Patients Who Are Inadequately Controlled with Basal Insulin Treatment: Randomized, Parallel, Open-Label, Active-Controlled Study. Journal of Korean Medical Science 29:1, pages 90.
Crossref
Monika Scheuringer, Narine Sahakyan, Karl J Krobot & Volker Ulrich. (2012) Cost of clinical events in health economic evaluations in Germany: a systematic review. Cost Effectiveness and Resource Allocation 10:1, pages 7.
Crossref
S. Gerkens, M. Nechelput, L. Annemans, B. Peraux, M. Mouchart, C. Beguin & Y. Horsmans. (2007) A health economic model to assess the cost-effectiveness of PEG IFN ?-2a and ribavirin in patients with mild chronic hepatitis C. Journal of Viral Hepatitis 14:8, pages 523-536.
Crossref
. (2013) Acarbose in diabetes gives value for money. PharmacoEconomics & Outcomes News 511:1, pages 8-8.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.